Telix Pharmaceuticals | TLX - Cost Of Sales

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD148.66M in Cost of Sales for its fiscal semester ending in December of 2024.





Cost Of Sales Change Date
Cochlear AUD 158.85M 131.25M Jun/2025
CSL USD 1.79B 2.15B Jun/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Medical Developments International AUD 2.18M 3.09M Jun/2025
Mesoblast USD 19.87M 34.61M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Polynovo AUD 4.77M 2.77M Jun/2024
Ramsay Health Care AUD 2.98B 742.1M Jun/2025
ResMed USD 536.28M 21.52M Dec/2025
Sonic Healthcare AUD 751.66M 801.13M Dec/2024